Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Pradelli

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Nutrition|August 19, 2021
Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic ReviewMaurizio Muscaritoli, Lorenzo Pradelli
Journal of Medical Economics|May 20, 2009
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluationLorenzo Pradelli, Sergio Iannazzo
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 26, 2009
The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov modelLorenzo Pradelli, Sergio Iannazzo, Orietta Zaniolo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 8, 2025
Cost-Effectiveness of a Ketoanalogue-supplemented Very Low-protein Diet in CKDPovero Massimiliano, Simion Tatiana, Lorenzo Pradelli
Clinicoeconomics and Outcomes Research : CEOR|February 19, 2021
Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in ItalyGianni Ghetti, Maria Claudia D'Avella, Lorenzo Pradelli
Clinical Drug Investigation|May 12, 2026
Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in ItalyGiuseppe Musumeci, Lorenzo Pradelli, Kelly Lee, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 8, 2012
A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in ItalyRoberto Walter Dal Negro, Silvia Tognella, Lorenzo Pradelli
Clinicoeconomics and Outcomes Research : CEOR|September 19, 2017
Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysisYufei Feng, Chao Li, Tian Zhang, et al.
Applied Health Economics and Health Policy|February 24, 2010
Organization and estimated patient-borne costs of oral anticoagulation therapy in Italy: results from a surveyLorenzo Pradelli, Sergio Iannazzo, Orietta Zaniolo, et al.
Critical Care (London, England)|October 6, 2012
n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysisLorenzo Pradelli, Konstantin Mayer, Maurizio Muscaritoli, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Nutrition|August 19, 2021
Medium-Chain Triglyceride (MCT) Content of Adult Enteral Tube Feeding Formulas and Clinical Outcomes. A Systematic ReviewMaurizio Muscaritoli, Lorenzo Pradelli
Journal of Medical Economics|May 20, 2009
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluationLorenzo Pradelli, Sergio Iannazzo
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 26, 2009
The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov modelLorenzo Pradelli, Sergio Iannazzo, Orietta Zaniolo
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 8, 2025
Cost-Effectiveness of a Ketoanalogue-supplemented Very Low-protein Diet in CKDPovero Massimiliano, Simion Tatiana, Lorenzo Pradelli
Clinicoeconomics and Outcomes Research : CEOR|February 19, 2021
Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in ItalyGianni Ghetti, Maria Claudia D'Avella, Lorenzo Pradelli
Clinical Drug Investigation|May 12, 2026
Cost-Effectiveness Analysis of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events in ItalyGiuseppe Musumeci, Lorenzo Pradelli, Kelly Lee, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 8, 2012
A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in ItalyRoberto Walter Dal Negro, Silvia Tognella, Lorenzo Pradelli
Clinicoeconomics and Outcomes Research : CEOR|September 19, 2017
Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysisYufei Feng, Chao Li, Tian Zhang, et al.
Applied Health Economics and Health Policy|February 24, 2010
Organization and estimated patient-borne costs of oral anticoagulation therapy in Italy: results from a surveyLorenzo Pradelli, Sergio Iannazzo, Orietta Zaniolo, et al.
Critical Care (London, England)|October 6, 2012
n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysisLorenzo Pradelli, Konstantin Mayer, Maurizio Muscaritoli, et al.
Pageof 7